期刊文献+

淋球菌对头孢曲松的敏感性及淋球菌多抗原测序分型研究 被引量:9

Ceftriaxone susceptibility testing and multi-antigen sequence typing of Neisseria gonorrhoeae strains isolatedin 2007 and 2012 ~from Nanjing~ China 1
原文传递
导出
摘要 目的探讨南京市淋球菌对头孢曲松的敏感性以及相应菌株的淋球菌多抗原测序分型(NG-MAST)基因型别。方法2007年和2012年在中国疾病预防控制中心性病控制中心临床防治基地分别收集了204株和81株淋球菌,经过分离纯化及鉴定后,用琼脂稀释法测定其对头孢曲松的最小抑菌浓度(Mm);菌株培养后利用试剂盒提取DNA,并进行淋球菌多抗原测序分型(NG-MAST)。结果测试的285株淋球菌MIC≥0.060Ixg/ml的菌株比例为63.2%,MIC≥0.125Ixg/ml的比例为31.6%。2012年MIC≥0.060Ixg/ml和MIC≥0.125IXg/ml的菌株比例分别为44.4%和11.1%,2007年MIC≥0.060斗g/ml和MIC≥0.125肛∥ml的菌株比例分别为70.6%和39.7%。NG—MAST分型研究显示,285株淋球菌共有166个型别,菌株多样性较高,其中73种为已知型别,93种为新型别。2007年测定的所有菌株中以sT568(n=13),ST270(n=9),ST421(n:7),ST2288(n=5),STl731(n=4),STl766(n=4),STl866(n=4),STl870(n:4)等为主。2012年测定的所有菌株中以ST2318(n=5),STl053(n=4),ST5990(n=4),ST8726(n=4)为主。相同NG-MAST型别的菌株具有相同或相近的MIC值。结论2012年与2007年菌株的优势型别有较大变化,某些型别与头孢药敏值有较强对应关系。NG-MAST分型可能作为分子生物学标记用于淋球菌耐药监测。 Objective To test the ceftriaxone susceptibility of Neisseria gonorrboeae (NG) isolates from Nanjing city, and to assess their genotypes by using the NG muhi-antigen sequence typing (NG-MAST) method. Methods A total of 204 NG strains isolated in 2007 and 81 in 2012 from Nanjing city were included in this study. The minimum inhibitory concentration (MIC) of ceftriaxone was determined for these strains using an agar dilution method. DNA was extracted by the Qiagen commercial kit from these strains followed by NG-MAST. Results All the isolates were susceptible to ceftriaxone (MIC, ≤ 0.25 ug/ml). The MIC of ceftriaxone was≥ 0.06 ug/ml for 63.2% of all the NG strains, 70.6% of those isolated in 2007 and 44.4% of those in 2012, and /〉 0.125 ug/ml for 31.6 % of all the NG strains, 39.7% of those isolated in 2007, 11.1% of those in 2012. Totally, 166 genotypes were identified among the 285 isolates, of which, 73 had been reported, and 93 were previously unreported. The most prevalent genotype was ST568 (n = 13) in NG strains isolated in 2007, followed by ST270 (n = 9), ST421 (n = 7), ST2288 (n = 5), ST1731 (n = 4), ST1766 (n = 4), ST1866 (n = 4), ST1870 (n = 4), while ST2318 (n = 5), ST1053 (n = 4), ST5990 (n = 4), ST8726 (n = 4) were the common genotypes in 2012. Those isolates with identical or similar genotypes tended to display similar MICs for ceftriaxone. Conclusions The prevalent genotypes of NG are markedly different between 2007 and 2012 in Nanjing region, and there is a strong association between the genotypes and ceftriaxone susceptibility of NG. NG-MAST results may serve as a genetic marker in the surveillance of antibiotic susceptibility in NG.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2014年第5期316-319,共4页 Chinese Journal of Dermatology
基金 基金项目:国家自然科学基金青年科学基金(81101294) 协和青年基金(3332013143)
关键词 奈瑟球菌 淋病 抗药性 头孢曲松 Neisseffa gonorrhoeae Drug resistance Ceftriaxone
  • 相关文献

参考文献14

  • 1苏晓红.淋球菌对广谱头孢菌素的耐药性及应对策略[J].中华皮肤科杂志,2013,46(5):301-304. 被引量:14
  • 2Ohnishi M,Golparian D,Shimuta K,et al.Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?:detailed characterization of the first strain with high-level resistance to ceftriaxone[J].Antimicrob Agents Chemother,2011,55(7):3538-3545. 被引量:1
  • 3Unemo M,Golparian D,Nicholas R,et al.High-level cefiximeand ceftriaxone-resistant Neisseria gonorrhoeae in France:novel penA mosaic allele in a successful international clone causes treatment failure[J].Antimicrob Agents Chemother,2012,56(3):1273-1280. 被引量:1
  • 4Camara J,Serra J,Ayats J,et al.Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia,Spain[J].J Antimicrob Chemother,2012,67(8):1858-1860. 被引量:1
  • 5Ison CA,Hussey J,Sankar KN,et al.Gonorrhoea treatment failures to cefixime and azithromycin in England,2010[J].Euro Surveill,2011,16(14):19833. 被引量:1
  • 6Unemo M,Golparian D,Hestner A.Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations,Sweden,July 2010[J].Euro Surveill,2011,16(6):19792. 被引量:1
  • 7Unemo M,Golparian D,Syversen G,et al.Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment,Norway,2010[J].Euro Surveill,2010,15(47):19721. 被引量:1
  • 8Heymans R,Bruisten SM,Golparian D,et al.Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam,the Netherlands[J].Antimicrob Agents Chemother,2012,56(3):1516-1522. 被引量:1
  • 9Tapsall J,Read P,Carmody C,et al.Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods[J].J Med Microbiol,2009,58(Pt 5):683-687. 被引量:1
  • 10Yokoi S,Deguchi T,Ozawa T,et al.Threat to cefixime treatment for gonorrhea[J].Emerg Infect Dis,2007,13(8):1275-1277. 被引量:1

二级参考文献25

  • 1World Health Organization (WHO). Global action plan to controlthe spread and impact of anti-microbial resistance in Neisseriagonorrhoeae [S/OL].2012-06-14. http:// whqlibdoc.who.int /publications /2012/9789241503501_eng.pdf. 被引量:1
  • 2Centers for Disease Control and Prevention (CDC). Cephalosporinsusceptibility among Neisseria gonorrhoeae isolates:UnitedStates,2000-2010. MMWR Morb Mortal Wkly Rep,2011,60(26):873-877. 被引量:1
  • 3Martin I,Sawatzky P,Allen V,et al. Emergence and characteri-zation of Neisseria gonorrhoeae isolates with decreased suscep-bilities to ceftriaxone and cefixime in Canada:2001-2010. SexTransm Dis,2012,39(4):316-323. 被引量:1
  • 4ECDC surveillance report. Gonococcal antimicrobial suscepti-bility surveillance in Europe 2010. Stockholm:ECDC,2012. 被引量:1
  • 5Lahra MM,Australian Gonococcal Surveillance Programme.Annual report of the Australian Gonococcal Surveillance Pro-gramme,2011. Commun Dis Intell,2012,36(2):el66-el73. 被引量:1
  • 6Lahra MM,WHO Western Pacific and South East Asian Gono-coccal Antimicrobial Surveillance Programme. Surveillance ofantibiotic resistance in Neisseria gonorrhoeae in the WHOWestern Pacific and South East Asian Regions,2010. CommunDis Intell,2012,36(1):95-100. 被引量:1
  • 7Allen VG,Mittemi L,Seah C,et al. Neisseria gonorrhoeae treat-ment failure and susceptibility to cefixime in Toronto,Canada.JAMA,2013,309(2):163-170. 被引量:1
  • 8Tapsall J,Read P,Carmody C,et al. Two cases of failed ceftriaxonetreatment in pharyngeal gonorrhoea verified by molecular micro-biological methods. J Med Microbiol,2009,58(Pt 5):683-687. 被引量:1
  • 9Ohnishi M,Saika T,Hoshina S,et al. Ceftriaxone-resistantNeisseria gonorrhoeae,Japan. Emerg Infect Dis,2011,17(1):148-149. 被引量:1
  • 10Centere for Disease Control and Prevention (CDC). Update toCDC,s Sexually transmitted diseases treatment guidelines,2010:oral cephalosporins no longer a recommended treatment forgonococcal infections. MMWR Morb Mortal Wkly Rep,2012,61(31):590-594. 被引量:1

共引文献13

同被引文献77

  • 1Ashford WA, Golash RG, Hemming VG. Penicillinase-producing Neissea gonorrhoeae[J]. Lancet, 1976, 2(7987): 657-658. 被引量:1
  • 2Phillips I. Beta-lactamase-producing, penicillin-resistant gonococcus [ J ]. Lancet, 1976, 2(7987 ): 656-657. 被引量:1
  • 3Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone[ J ]. Antimicrob Agents Chemother, 2011, 55 (7): 3538- 3545. 被引量:1
  • 4Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure [ J ]. Antimicrob Agents Chemother, 2012, 56 ( 3 ): 1273-1280. 被引量:1
  • 5Ctmara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftrlaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain [J ]. J Antimicrob Chemother, 2012, 67 (8): 1858-1860. 被引量:1
  • 6Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010 [J/OL]. Euro Surveill, 2011, 16 (14). pii: 19833 [2014-10-10]. http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId= 19833. 被引量:1
  • 7Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010[J/OL]. Euro Surveill, 2011, 16(6). pii: 19792 [2014-10-10]. http://www.eurosurveillance.org/ViewArticle.aspx? Article/d= 19792. 被引量:1
  • 8Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010 [J/OL]. Euro Surveill, 2010, 15 (47). pii: 19721 [2014-10-10]. http://www. eurosurveillanee.org/ViewArticle.aspx?Articleld= 19721. 被引量:1
  • 9Unemo M, Golparian D, Potocnik M, et al. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011 [J/OL]. Euro Surveill, 2012, 17 (25). pii: 20200 [2014-10-10]. http://www. eurosurveillance.org/ViewArticle.aspx?Artieleld=20200. 被引量:1
  • 10Tapsall J, Read P, Carmody C, et al. Two cases of failed eeftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods [J]. J Med Microbiol, 2009, 58 (5): 683- 687. 被引量:1

引证文献9

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部